J&J Cites Neutroqena Among 20 Product Launches Planned For 2015

摘要

U.S. growth helped drive a slight increase in Johnson & Johnson's worldwide consumer product sales in the fourth quarter, providing momentum for a segment with plans for 20 product launches in 2015 following a full-year sales dip of 1.4%. Skin care led U.S. consumer growth of 2.5% to $1.3 billion for the October-December period on a reported basis, according to J&J's Jan. 20 earnings statement, which cited Aveeno and Neutroqena as standout contributors. Global sales in the firm's consumer health business increased 0.9% to $3.6 billion for the quarter, reported, with analgesics and upper respiratory products propelling OTC sales growth, J&J said.